Joint Oligopsony‐Oligopoly Power in Food Processing Industries: Application to the us Broiler Industry

2020 ◽  
Author(s):  
Stephen F. Hamilton ◽  
David L. Sunding
Keyword(s):  
Food Processing ◽  
Broiler Industry ◽  
The Us

Inter-industry technology flows in the US food-processing industries

1986 ◽  
Vol 7 (3) ◽  
pp. 163-168 ◽  
Author(s):  
Willard F. Mueller ◽  
John D. Culbertson
Keyword(s):  
Food Processing ◽  
The Us

Economic value and cost of automated on-line poultry inspection for the US broiler industry

Food Control ◽  
1999 ◽  
Vol 10 (2) ◽  
pp. 69-80 ◽  
Author(s):  
B Watkins
Keyword(s):  
Economic Value ◽  
Broiler Industry ◽  
The Us ◽  
On Line

scholarly journals Agroterrorism in the U.S.: An Overview

EDIS ◽  
2009 ◽  
Vol 2009 (5) ◽  
Author(s):  
Renée M. Goodrich Schneider ◽  
Keith R. Schneider ◽  
C. D. Webb ◽  
Mike Hubbard ◽  
Douglas L. Archer
Keyword(s):  
Food Processing ◽  
Processing System ◽  
Biological Agents ◽  
Human Nutrition ◽  
Biological Warfare ◽  
Food Science ◽  
Fact Sheet ◽  
The Us ◽  
The U.S

Revised! FSHN-05-21, a 4-page fact sheet by R. Goodrich Schneider, K.R. Schneider, C.D. Webb, M. Hubbard, and D.L. Archer, discusses the use of biological agents in a deliberate, harmful attack, or terrorism using the weapons of biological warfare against the U.S. agricultural and food processing system. Includes references. Published by the UF Department of Food Science and Human Nutrition, April 2009. FSHN0521/FS126: Agroterrorism in the US: An Overview (ufl.edu)

scholarly journals Avian Pathogenic Escherichia coli and Clostridium perfringens: Challenges in No Antibiotics Ever Broiler Production and Potential Solutions

2020 ◽  
Vol 8 (10) ◽  
pp. 1533
Author(s):  
Courtney A. Fancher ◽  
Li Zhang ◽  
Aaron S. Kiess ◽  
Pratima A. Adhikari ◽  
Thu T.N. Dinh ◽  
...  
Keyword(s):  
Escherichia Coli ◽  
Clostridium Perfringens ◽  
Pathogenic Bacteria ◽  
Management Strategies ◽  
Necrotic Enteritis ◽  
Broiler Meat ◽  
Broiler Industry ◽  
Broiler Production ◽  
Pathogenic Escherichia Coli ◽  
The Us

United States is the largest producer and the second largest exporter of broiler meat in the world. In the US, broiler production is largely converting to antibiotic-free programs which has caused an increase in morbidity and mortality within broiler farms. Escherichia coli and Clostridium perfringens are two important pathogenic bacteria readily found in the broiler environment and result in annual billion-dollar losses from colibacillosis, gangrenous dermatitis, and necrotic enteritis. The broiler industry is in search of non-antibiotic alternatives including novel vaccines, prebiotics, probiotics, and housing management strategies to mitigate production losses due to these diseases. This review provides an overview of the broiler industry and antibiotic free production, current challenges, and emerging research on antibiotic alternatives to reduce pathogenic microbial presence and improve bird health.

scholarly journals What Drives Firm Profitability? A Comparison of the US and EU Food Processing Industry

2017 ◽  
Vol 86 (3) ◽  
pp. 390-416 ◽  
Author(s):  
Adelina Gschwandtner ◽  
Stefan Hirsch
Keyword(s):  
Food Processing ◽  
Food Processing Industry ◽  
Processing Industry ◽  
The Us ◽  
Firm Profitability

FORDISM, FLEXIBLE SPECIALIZATION AND AGRI-INDUSTRIAL RESTRUCTURING: The Case of the US Broiler Industry

1993 ◽  
Vol 33 (1) ◽  
pp. 61-80 ◽  
Author(s):  
CHUL-KYOO KIM ◽  
JAMES CURRY
Keyword(s):  
Industrial Restructuring ◽  
Broiler Industry ◽  
Flexible Specialization ◽  
The Us

The Eleventh Circuit Holds that Agreements in which Pharmaceutical Companies Pay Generic Companies Not to Compete May be Valid

2004 ◽  
Vol 32 (1) ◽  
pp. 181-184
Author(s):  
Amy Garrigues
Keyword(s):  
Pharmaceutical Companies ◽  
Court Decisions ◽  
Patent Holder ◽  
Trial Court ◽  
Court Of Appeals ◽  
The Us ◽  
Antitrust Laws ◽  
Per Se ◽  
Appeals Court ◽  
Two Sides

On September 15, 2003, the US. Court of Appeals for the Eleventh Circuit held that agreements between pharmaceutical and generic companies not to compete are not per se unlawful if these agreements do not expand the existing exclusionary right of a patent. The Valley DrugCo.v.Geneva Pharmaceuticals decision emphasizes that the nature of a patent gives the patent holder exclusive rights, and if an agreement merely confirms that exclusivity, then it is not per se unlawful. With this holding, the appeals court reversed the decision of the trial court, which held that agreements under which competitors are paid to stay out of the market are per se violations of the antitrust laws. An examination of the Valley Drugtrial and appeals court decisions sheds light on the two sides of an emerging legal debate concerning the validity of pay-not-to-compete agreements, and more broadly, on the appropriate balance between the seemingly competing interests of patent and antitrust laws.

Sign in / Sign up

Export Citation Format

Share Document